Designer  20261102T143644645

Saxo Investor Radar, Oct 2026: Singapore investors bought Alphabet and DBS, but sold Microsoft

Equities 6 minutes to read

Nvidia remained a favourite, but October brought some surprises. Buying strengthened across selected AI stocks and Singapore banks, while Tesla and Microsoft saw greater selling pressure. Beyond equities, investors also appeared to favour shorter-term Treasury exposure.

Here's where investor behaviour changed most noticeably.

1. Buying the AI dip? Investors become more selective

AI remained firmly on investors' radar, but buying interest wasn't limited to the familiar semiconductor giants. Cloud infrastructure, memory and storage stocks also attracted stronger buying than in previous months.

Stock

October buying

Shift vs previous 3 months

What's driving interest?

Alphabet (GOOGL)

86% buys

+11 pp

Shares tumbled after earnings amid concerns over AI spending. Buying strengthened during a volatile month, possibly after the earnings dip.

Nvidia (NVDA)

65% buys

+11 pp

Investors continued buying despite questions over AI valuations and the sustainability of infrastructure spending.

CoreWeave (CRWV)

80% buys

+17 pp

Buying strengthened despite a sharp selloff driven by concerns over its debt-funded AI expansion and refinancing risks.

Cerebras (CBRS)

82% buys

+16 pp

Interest grew amid volatility surrounding AI chip competition, customer concentration and post-IPO share supply.

SK hynix (ADR)

77% buys

+11 pp

Strong earnings and booming demand for high-bandwidth memory kept the AI memory trade in focus.

Seagate (STX)

71% buys

+20 pp

One of the sharpest buying shifts as AI-driven data storage demand attracted attention beyond chips.

The takeaway: Investors weren't abandoning AI. They were becoming more selective, with stronger buying across parts of the AI infrastructure and memory value chains, even as financing and valuation risks intensified.

2. Singapore banks: Buying the pullback?

October's volatility brought renewed attention to Singapore banks. Despite concerns over interest margins, earnings and valuations, buying became considerably stronger than in the preceding three months.

Stock

Change in trading clients vs September

October buying

Shift vs previous 3 months

What's driving interest?

DBS (D05)

+191%

87% buys

+16 pp

Buying intensified amid the banking-sector pullback, with dividends and earnings resilience remaining attractive.

OCBC (O39)

+159%

88% buys

+15 pp

Stronger buying despite concerns over net interest margins and the sector's earnings outlook.

The takeaway: While US technology remained in focus, Singapore banks saw a meaningful increase in participation and buying appetite. Was October's weakness an opportunity for income-focused investors?

3. Heading for the exit? Where selling intensified

Not every technology favourite enjoyed stronger buying. Some established names saw a notable shift towards selling as investors reassessed valuations, earnings and future returns on AI spending.

Stock

October selling

Shift vs previous 3 months

What's driving interest?

Tesla (TSLA)

63% sells

+22 pp

Selling intensified amid questions over automotive growth, valuations and the execution of its autonomy ambitions.

Microsoft (MSFT)

77% sells

+13 pp

Rising AI capital expenditure and questions about monetisation weighed on sentiment despite strong cloud demand.

Oracle (ORCL)

43% sells

+14 pp

Selling increased relative to recent months as investors questioned AI infrastructure financing and cash-flow requirements.

The takeaway: AI exposure was not uniformly popular. Investors appeared more cautious about companies facing large spending commitments and uncertainty over the timing of returns.

4. Beyond AI: The unexpected movers

Healthcare, Southeast Asian technology, quantum computing and Treasury bonds also saw some interesting changes in investor behaviour.

Stock / ETF

October trading signal

What's driving interest?

Moderna (MRNA)

Trading activity +89% vs September; 54% sells

Shares plunged following promising cancer-vaccine results, as investors reassessed expectations after an earlier rally. The volatility sparked a sharp increase in trading activity.

Sea Limited (SE)

Trading clients +91%; 74% buys, up 35 pp

Buying appetite strengthened sharply for the Southeast Asian e-commerce, gaming and fintech company.

Eli Lilly (LLY)

61% sells, up 27 pp

Selling intensified despite robust obesity-drug demand and an improved revenue outlook.

D-Wave Quantum (QBTS)

Trading clients +47%; 81% buys

Quantum computing continued to attract speculative interest, even as commercialisation timelines and valuations remained uncertain.

iShares USD Treasury Bond 0–1yr UCITS ETF

Trading clients +56%; 75% buys, up 12 pp

Short-term US Treasuries attracted stronger buying as investors sought income with relatively limited interest-rate sensitivity.

iShares 20+ Year Treasury Bond ETF (TLT)

Trading clients −10%; buy share down 22 pp

Interest in longer-duration bonds weakened amid inflation uncertainty and volatile bond yields.

The takeaway: Beyond individual stocks, investors showed a greater preference for short-term Treasury exposure over long-duration bonds. Meanwhile, healthcare and emerging technology stocks generated fresh trading opportunities and volatility.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.